Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Non-Current Deffered Revenue (2024 - 2025)

AC Immune (ACIU) has disclosed Non-Current Deffered Revenue for 1 consecutive years, with $5.2 million as the latest value for Q4 2024.

  • On a quarterly basis, Non-Current Deffered Revenue changed N/A to $5.2 million in Q4 2024 year-over-year; TTM through Dec 2024 was $5.2 million, a N/A change, with the full-year FY2024 number at $5.2 million, changed N/A from a year prior.
  • Non-Current Deffered Revenue was $5.2 million for Q4 2024 at AC Immune.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $5.2 million in Q4 2024 to a low of $5.2 million in Q4 2024.